Literature DB >> 24145021

Pharmacokinetics and pharmacodynamics of imipenem and meropenem in critically ill patients treated with continuous venovenous hemodialysis.

David Afshartous1, Seth R Bauer2, Michael J Connor3, Olufemi A Aduroja2, Milen Amde2, Charbel Salem2, Joseph J Groszek1, William H Fissell4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24145021      PMCID： PMC4933593          DOI： 10.1053/j.ajkd.2013.08.015

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN： 0272-6386            Impact factor:   8.860


× No keyword cloud information.
  4 in total

Review 1.  Antimicrobial pharmacodynamics: critical interactions of 'bug and drug'.

Authors:  George L Drusano
Journal:  Nat Rev Microbiol       Date:  2004-04       Impact factor: 60.633

2.  Pharmacokinetics and pharmacodynamics of piperacillin-tazobactam in 42 patients treated with concomitant CRRT.

Authors:  Seth R Bauer; Charbel Salem; Michael J Connor; Joseph Groszek; Maria E Taylor; Peilin Wei; Ashita J Tolwani; William H Fissell
Journal:  Clin J Am Soc Nephrol       Date:  2012-01-26       Impact factor: 8.237

3.  Intensity of continuous renal-replacement therapy in critically ill patients.

Authors:  Rinaldo Bellomo; Alan Cass; Louise Cole; Simon Finfer; Martin Gallagher; Serigne Lo; Colin McArthur; Shay McGuinness; John Myburgh; Robyn Norton; Carlos Scheinkestel; Steve Su
Journal:  N Engl J Med       Date:  2009-10-22       Impact factor: 91.245

4.  Intensity of renal support in critically ill patients with acute kidney injury.

Authors:  Paul M Palevsky; Jane Hongyuan Zhang; Theresa Z O'Connor; Glenn M Chertow; Susan T Crowley; Devasmita Choudhury; Kevin Finkel; John A Kellum; Emil Paganini; Roland M H Schein; Mark W Smith; Kathleen M Swanson; B Taylor Thompson; Anitha Vijayan; Suzanne Watnick; Robert A Star; Peter Peduzzi
Journal:  N Engl J Med       Date:  2008-05-20       Impact factor: 91.245
  4 in total
  7 in total

1.  Staying on target with continuous dialysis.

Authors:  Sevag Demirjian; William H Fissell
Journal:  Clin J Am Soc Nephrol       Date:  2014-12-23       Impact factor: 8.237

2.  Doripenem Treatment during Continuous Renal Replacement Therapy.

Authors:  M G Vossen; J M Wenisch; A Maier-Salamon; A Fritsch; K Saria; C Zuba; S Jilch; R Lemmerer; M Unger; U Jaehde; W Jäger; F Thalhammer
Journal:  Antimicrob Agents Chemother       Date:  2015-12-28       Impact factor: 5.191

3.  Pharmacokinetics of benapenem for injection in subjects with mild to moderate renal impairment.

Authors:  Haijing Yang; Min Zhang; Yuancheng Chen; Hong Ren; Hong Zhang; Chen Yu; Jianda Lu; Li You; Jicheng Yu; Hong Liang; Cuilan Xiao; Zishuang He; Jufang Wu; Jun Xue; Jing Zhang
Journal:  Eur J Clin Pharmacol       Date:  2022-04-06       Impact factor: 2.953

4.  Pharmacokinetics and Pharmacodynamics of Extended Infusion Versus Short Infusion Piperacillin-Tazobactam in Critically Ill Patients Undergoing CRRT.

Authors:  Matthew S Shotwell; Ross Nesbitt; Phillip N Madonia; Edward R Gould; Michael J Connor; Charbel Salem; Olufemi A Aduroja; Milen Amde; Joseph J Groszek; Peilin Wei; Maria E Taylor; Ashita J Tolwani; William H Fissell
Journal:  Clin J Am Soc Nephrol       Date:  2016-05-19       Impact factor: 8.237

5.  Meropenem Stability in Human Plasma at -20 °C: Detailed Assessment of Degradation.

Authors:  Matthias Gijsen; Benjamin Filtjens; Pieter Annaert; Yeghig Armoudjian; Yves Debaveye; Joost Wauters; Peter Slaets; Isabel Spriet
Journal:  Antibiotics (Basel)       Date:  2021-04-16

6.  Pharmacokinetics of meropenem in septic patients on sustained low-efficiency dialysis: a population pharmacokinetic study.

Authors:  Stephan Braune; Christina König; Jason A Roberts; Axel Nierhaus; Oliver Steinmetz; Michael Baehr; Stefan Kluge; Claudia Langebrake
Journal:  Crit Care       Date:  2018-01-30       Impact factor: 9.097

Review 7.  Recommendation of Antimicrobial Dosing Optimization During Continuous Renal Replacement Therapy.

Authors:  Lu Li; Xin Li; Yanzhe Xia; Yanqi Chu; Haili Zhong; Jia Li; Pei Liang; Yishan Bu; Rui Zhao; Yun Liao; Ping Yang; Xiaoyang Lu; Saiping Jiang
Journal:  Front Pharmacol       Date:  2020-05-29       Impact factor: 5.810
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.